CXCL13 Anti-Human 100 µg

In stock

Cat-Nr.
101-M351
Size
100 µg
  €533.00

Description / CXCL13

NAP-2 or CXCL7 is a CXC chemokine that can signal through the CXCR1 and CXCR2 receptors. It is produced in leukocytes by enzymatic processing of a precursor called platelet basic protein (PBP). NAP-2 chemoattracts and activates neutrophils. Recombinant human NAP-2 protein is a 7.6 kDa protein containing 70 amino acid residues including the four highly conserved cysteine residues present in CXC chemokines, and also including the “ELR” motif common to CXC chemokines that bind to CXCR1 and CXCR2.

More Information

Size 100 µg
Source Mouse
Isotype IgG1
Clone Nr. (#12A2)
Species Reactivity Human
Formulation lyophilized
Buffer PBS
Reconstitution Centrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.
Stability and Storage Lyophilized samples are stable for 2 years from date of receipt when stored at -70°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity.
Preparation This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse) immunized with human recombinant CXCL13 (also called BCL). The IgG1 fraction of the tissue culture supernatant was purified by Protein G affinity chromatograp
Antigen human recombinant CXCL13
Application WB, N
Synonyms CXCL13; BLC; BCA1; ANGIE; BCA-1; BLR1L; ANGIE2; SCYB13
Uniprot ID O43927
Protein RefSeq NP_006410.1
mRNA RefSeq NM_006419.2

All prices plus VAT + possible delivery charges